The CVDPREVENT Audit has published its third annual audit report. Covering the audit period up to March 2022, it provides insight into the impact of the COVID-19 pandemic on primary care services (diagnosis and management of hypertension were significantly disrupted) and compares the national position against key ambitions identified as milestones for the prevention of CVD; the detection and management of atrial fibrillation, blood pressure and cholesterol.
Key findings include:
The prevalence of cardiovascular disease in adults in England was 6.0%. The prevalence increased with age and males were more likely than females to have the disease
Prescription of anticoagulation drug therapy, for those with AF at high-risk of stroke, increased by one percentage point since March 2021 to 88.9% in March 2022
Nearly 20% of people with CVD did not have a recorded current prescription of lipid lowering therapy (secondary prevention).
This report also includes findings relating to diagnoses of chronic kidney disease and diabetes; lifestyle; and health inequalities, as well as a number of recommendations to support the prevention of cardiovascular disease.
Read the full report: You can read the report by clicking on the link below.
Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
